TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 15 | 10 | 3 | -6 | 13 | 6 | 7 |
| P | %wins | 100 | 100 | 100 | 0 | 100 | 100 | 83 | |||
| S | %ret | 2 | 1 | 3 | -1 | 1 | -4 | -27 | -22 | -25 | -13 |
| S | %wins | 67 | 67 | 67 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/15/14 16:30 | 8/13/14 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Bronfeld Zeev | L3 | DT | S | -10,868 | 2.47 | 1 | -4,400 | -30 | 10,066 | I | -53 | -46 | -43 | -28 | -22 | -22 | -13 | -7 | -3 | -10 | -8 | -27 | -32 | -40 | |
10/5/11 21:56 | 9/27/11 | ORMP | Oramed Pharmaceuticals Inc. | NV | Health | Drug | Pharmaceutical Preparations | Bronfeld Zeev | L3 | T | S.a | -98 | 0.2800 | 0 | -350 | -5 | 6,590 | D | -34 | -8 | 16 | 16 | 37 | 37 | 32 | 19 | -4 | -5 | -16 | -40 | -27 | -32 | |
9/28/11 14:53 | 9/27/11 | ORMP | Oramed Pharmaceuticals Inc. | NV | Health | Drug | Pharmaceutical Preparations | Bronfeld Zeev | L3 | T | S | -98 | 0.2800 | 0 | -350 | -5 | 6,590 | D | -40 | -23 | 19 | -3 | 7 | 11 | 3 | 3 | 3 | 19 | 13 | -13 | -6 | -3 | |
4/4/11 14:27 | 3/31/11 | ORMP | Oramed Pharmaceuticals Inc. | NV | Health | Drug | Pharmaceutical Preparations | Bronfeld Zeev | L3 | T | P.d | 250 | 0.3200 | 0 | 781 | 12 | 7,213 | I | -11 | -35 | -23 | 3 | 3 | 7 | 15 | 19 | 15 | 10 | 3 | -6 | 13 | 6 | |
5/4/07 16:22 | 4/30/07 | GEYI | Global Energy Inc | NV | BizSv | BizSv | Business Services | Bronfeld Zeev | L3 | T | P | 300 | 0.0100 | 0 | 30,000 | 250 | 42,000 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |